Search research articles
Contact Us
Filters
Showing results (71-80 of 133) with videos related to
Page
of 14
Sort By:
Biomedicines
|
May 28, 2022
Evaluation in a Cytokine Storm Model In Vivo of the Safety and Efficacy of Intravenous Administration of PRS CK STORM (Standardized Conditioned Medium Obtained by Coculture of Monocytes and Mesenchymal Stromal Cells)
Juan Pedro Lapuente, Gonzalo Gómez, Joaquín Marco-Brualla, et al.
Journal of Crohn'S & Colitis
|
March 9, 2012
Induction of psoriasis with anti-TNF agents in patients with inflammatory bowel disease: a report of 21 cases
Iván Guerra, Alicia Algaba, José Lázaro Pérez-Calle, et al.
Digestive Diseases and Sciences
|
December 21, 2016
Adalimumab Maintenance Treatment in Ulcerative Colitis: Outcomes by Prior Anti-TNF Use and Efficacy of Dose Escalation
Carlos Taxonera, Eva Iglesias, Fernando Muñoz, et al.
Gastroenterologia Y Hepatologia
|
June 26, 2016
IV Spanish Consensus Conference on Helicobacter pylori infection treatment
Javier P Gisbert, Javier Molina-Infante, Javier Amador, et al.
Inflammatory Bowel Diseases
|
February 2, 2021
Re-induction With Intravenous Ustekinumab in Patients With Crohn's Disease and a Loss of Response to This Therapy
Fernando Bermejo, Laura Jiménez, Alicia Algaba, et al.
Biomolecules
|
April 23, 2022
Cytokine Profile and Anti-Inflammatory Activity of a Standardized Conditioned Medium Obtained by Coculture of Monocytes and Mesenchymal Stromal Cells (PRS CK STORM)
Juan Pedro Lapuente, Alejandro Blázquez-Martínez, Joaquín Marco-Brualla, et al.
Gastroenterologia Y Hepatologia
|
July 5, 2011
Adalimumab is effective in long-term real life clinical practice in both luminal and perianal Crohn's disease. The Madrid experience
José Ignacio Fortea-Ormaechea, Yago González-Lama, Begoña Casis, et al.
Digestive Diseases and Sciences
|
June 6, 2015
Infliximab Dose Escalation as an Effective Strategy for Managing Secondary Loss of Response in Ulcerative Colitis
Carlos Taxonera, Manuel Barreiro-de Acosta, Marta Calvo, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
March 14, 2020
Idiopathic acute pancreatitis in patients with inflammatory bowel disease: A multicenter cohort study
Ana Garcia Garcia de Paredes, Enrique Rodriguez de Santiago, Carlos Rodriguez-Escaja, et al.
Journal of Crohn'S & Colitis
|
January 21, 2016
Outcomes of Medical and Surgical Therapy for Entero-urinary Fistulas in Crohn's Disease
Carlos Taxonera, Manuel Barreiro-de-Acosta, Guillermo Bastida, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 133) with videos related to
Sort By:
Page
of 14
Biomedicines
|
May 28, 2022
Evaluation in a Cytokine Storm Model In Vivo of the Safety and Efficacy of Intravenous Administration of PRS CK STORM (Standardized Conditioned Medium Obtained by Coculture of Monocytes and Mesenchymal Stromal Cells)
Juan Pedro Lapuente, Gonzalo Gómez, Joaquín Marco-Brualla, et al.
Journal of Crohn'S & Colitis
|
March 9, 2012
Induction of psoriasis with anti-TNF agents in patients with inflammatory bowel disease: a report of 21 cases
Iván Guerra, Alicia Algaba, José Lázaro Pérez-Calle, et al.
Digestive Diseases and Sciences
|
December 21, 2016
Adalimumab Maintenance Treatment in Ulcerative Colitis: Outcomes by Prior Anti-TNF Use and Efficacy of Dose Escalation
Carlos Taxonera, Eva Iglesias, Fernando Muñoz, et al.
Gastroenterologia Y Hepatologia
|
June 26, 2016
IV Spanish Consensus Conference on Helicobacter pylori infection treatment
Javier P Gisbert, Javier Molina-Infante, Javier Amador, et al.
Inflammatory Bowel Diseases
|
February 2, 2021
Re-induction With Intravenous Ustekinumab in Patients With Crohn's Disease and a Loss of Response to This Therapy
Fernando Bermejo, Laura Jiménez, Alicia Algaba, et al.
Biomolecules
|
April 23, 2022
Cytokine Profile and Anti-Inflammatory Activity of a Standardized Conditioned Medium Obtained by Coculture of Monocytes and Mesenchymal Stromal Cells (PRS CK STORM)
Juan Pedro Lapuente, Alejandro Blázquez-Martínez, Joaquín Marco-Brualla, et al.
Gastroenterologia Y Hepatologia
|
July 5, 2011
Adalimumab is effective in long-term real life clinical practice in both luminal and perianal Crohn's disease. The Madrid experience
José Ignacio Fortea-Ormaechea, Yago González-Lama, Begoña Casis, et al.
Digestive Diseases and Sciences
|
June 6, 2015
Infliximab Dose Escalation as an Effective Strategy for Managing Secondary Loss of Response in Ulcerative Colitis
Carlos Taxonera, Manuel Barreiro-de Acosta, Marta Calvo, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
March 14, 2020
Idiopathic acute pancreatitis in patients with inflammatory bowel disease: A multicenter cohort study
Ana Garcia Garcia de Paredes, Enrique Rodriguez de Santiago, Carlos Rodriguez-Escaja, et al.
Journal of Crohn'S & Colitis
|
January 21, 2016
Outcomes of Medical and Surgical Therapy for Entero-urinary Fistulas in Crohn's Disease
Carlos Taxonera, Manuel Barreiro-de-Acosta, Guillermo Bastida, et al.
Page
of 14